معرفی
Shuqin Cao serves as a Research Fellow in the Department of Clinical Molecular Biology within the Faculty of Medicine at the University of Oslo. Based at Akershus University Hospital in Nordbyhagen, Norway, Dr. Cao conducts research at the intersection of molecular biology and disease mechanisms, with a focus on neurodegenerative disorders and cancer biology.
Her primary research areas include Alzheimer's disease pathology, mitochondrial homeostasis, and mitophagy regulation. She employs cross-species models (C. elegans, mice, human tissues) and integrates techniques like luminescent-based metabolic assays and machine learning for drug discovery. Current work investigates the FOXO3/DAF-16 pathway in aging models and iron metabolism dysregulation in disease contexts.
Analysis of Dr. Cao's 2020-2024 publications reveals a cohesive research trajectory centered on cellular quality control mechanisms in neurodegeneration and cancer. Key themes include NAD+/NADH detection assay development, natural compound neuroprotection against amyloid-beta toxicity, and machine learning-identified mitophagy inducers for Alzheimer's therapy. The work consistently bridges molecular pathways with translational applications across species.
